These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 18925631

  • 21. Antitumor effects of interleukin-18 gene-modified hepatocyte cell line on implanted liver carcinoma.
    Leng J, Zhang L, Yao H, Cao X.
    Chin Med J (Engl); 2003 Oct; 116(10):1475-9. PubMed ID: 14570604
    [Abstract] [Full Text] [Related]

  • 22. [Anti-hepatocarcinoma effect of recombinant adenovirus carrying melittin gene].
    Ling CQ, Li B, Zhang C, Gu W, Li SX, Huang XQ, Zhang YN.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):741-4. PubMed ID: 15619342
    [Abstract] [Full Text] [Related]

  • 23. Characterization of glucocorticoid receptor and hepatocyte nuclear factor 4alpha (HNF4alpha) binding to the hnf4alpha gene in the liver.
    Bailly A, Briançon N, Weiss MC.
    Biochimie; 2009 Sep; 91(9):1095-103. PubMed ID: 19540905
    [Abstract] [Full Text] [Related]

  • 24. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
    Takano K, Hasegawa G, Jiang S, Kurosaki I, Hatakeyama K, Iwanari H, Tanaka T, Hamakubo T, Kodama T, Naito M.
    Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
    [Abstract] [Full Text] [Related]

  • 25. Hepatocyte nuclear factor-4alpha promotes gut neoplasia in mice and protects against the production of reactive oxygen species.
    Darsigny M, Babeu JP, Seidman EG, Gendron FP, Levy E, Carrier J, Perreault N, Boudreau F.
    Cancer Res; 2010 Nov 15; 70(22):9423-33. PubMed ID: 21062980
    [Abstract] [Full Text] [Related]

  • 26. Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression.
    Ning BF, Ding J, Liu J, Yin C, Xu WP, Cong WM, Zhang Q, Chen F, Han T, Deng X, Wang PQ, Jiang CF, Zhang JP, Zhang X, Wang HY, Xie WF.
    Hepatology; 2014 Nov 15; 60(5):1607-19. PubMed ID: 24752868
    [Abstract] [Full Text] [Related]

  • 27. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
    Yoon SK, Armentano D, Wands JR, Mohr L.
    Cancer Gene Ther; 2001 Aug 15; 8(8):573-9. PubMed ID: 11571535
    [Abstract] [Full Text] [Related]

  • 28. AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice.
    Zhang Y, Ma H, Zhang J, Liu S, Liu Y, Zheng D.
    Life Sci; 2008 Jun 06; 82(23-24):1154-61. PubMed ID: 18485417
    [Abstract] [Full Text] [Related]

  • 29. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis.
    Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, Ning G, Kaestner KH, Rossi JM, Zaret KS, Duncan SA.
    Nat Genet; 2003 Jul 06; 34(3):292-6. PubMed ID: 12808453
    [Abstract] [Full Text] [Related]

  • 30. Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development.
    Kamiya A, Inoue Y, Gonzalez FJ.
    Hepatology; 2003 Jun 06; 37(6):1375-84. PubMed ID: 12774017
    [Abstract] [Full Text] [Related]

  • 31. Convergence of Wnt signaling on the HNF4alpha-driven transcription in controlling liver zonation.
    Colletti M, Cicchini C, Conigliaro A, Santangelo L, Alonzi T, Pasquini E, Tripodi M, Amicone L.
    Gastroenterology; 2009 Aug 06; 137(2):660-72. PubMed ID: 19454287
    [Abstract] [Full Text] [Related]

  • 32. The stable repression of mesenchymal program is required for hepatocyte identity: a novel role for hepatocyte nuclear factor 4α.
    Santangelo L, Marchetti A, Cicchini C, Conigliaro A, Conti B, Mancone C, Bonzo JA, Gonzalez FJ, Alonzi T, Amicone L, Tripodi M.
    Hepatology; 2011 Jun 06; 53(6):2063-74. PubMed ID: 21384409
    [Abstract] [Full Text] [Related]

  • 33. Abrogating K458 acetylation enhances hepatocyte nuclear factor 4α (HNF4α)-induced differentiation therapy for hepatocellular carcinoma.
    Liu F, Peng Y, Qian H, Xiao MC, Ding CH, Zhang X, Xie WF.
    J Dig Dis; 2024 Apr 06; 25(4):255-265. PubMed ID: 38837552
    [Abstract] [Full Text] [Related]

  • 34. Treatment of hepatocellular carcinoma with adenoviral vector-mediated Flt3 ligand gene therapy.
    Wang H, Dai J, Hou S, Qian W, Li B, Ma J, Fan X, Zhao J, Yang S, Sang H, Yang Q, Wang R, Guo Y.
    Cancer Gene Ther; 2005 Sep 06; 12(9):769-77. PubMed ID: 15877081
    [Abstract] [Full Text] [Related]

  • 35. Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation.
    Wu N, Zhang YL, Wang HT, Li DW, Dai HJ, Zhang QQ, Zhang J, Ma Y, Xia Q, Bian JM, Hang HL.
    Cancer Biol Ther; 2016 May 03; 17(5):558-65. PubMed ID: 27124543
    [Abstract] [Full Text] [Related]

  • 36. Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.
    Maeda Y, Hwang-Verslues WW, Wei G, Fukazawa T, Durbin ML, Owen LB, Liu X, Sladek FM.
    Biochem J; 2006 Dec 01; 400(2):303-13. PubMed ID: 16895524
    [Abstract] [Full Text] [Related]

  • 37. Local delivery of recombinant adenovirus expressing hepatitis B virus X protein and interleukin-12 results in antitumor effects via inhibition of hepatoma cell growth and intervention of tumor microenvironment.
    He H, Fan P, Yin T, Chen Q, Shi H, Liu S, Li H, Jing Q, Yan Y, Zhang H, Yang L, Wen Y, Li Y, Cheng P.
    Int J Mol Med; 2012 Sep 01; 30(3):599-605. PubMed ID: 22710287
    [Abstract] [Full Text] [Related]

  • 38. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
    Tanaka T, Jiang S, Hotta H, Takano K, Iwanari H, Sumi K, Daigo K, Ohashi R, Sugai M, Ikegame C, Umezu H, Hirayama Y, Midorikawa Y, Hippo Y, Watanabe A, Uchiyama Y, Hasegawa G, Reid P, Aburatani H, Hamakubo T, Sakai J, Naito M, Kodama T.
    J Pathol; 2006 Apr 01; 208(5):662-72. PubMed ID: 16400631
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of hepatitis B Virus replication by hepatocyte nuclear factor 4-alpha specific short hairpin RNA.
    He F, Chen EQ, Liu L, Zhou TY, Liu C, Cheng X, Liu FJ, Tang H.
    Liver Int; 2012 May 01; 32(5):742-51. PubMed ID: 22340507
    [Abstract] [Full Text] [Related]

  • 40. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RC, McMasters KM.
    Cancer Gene Ther; 2002 May 01; 9(5):453-63. PubMed ID: 11961668
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.